Akifumi Morinaka
Director/Board Member at Rege Nephro Co. Ltd.
Akifumi Morinaka active positions
| Companies | Position | Start | End |
|---|---|---|---|
JAFCO Group Co. Ltd. (Private Equity)
 JAFCO Group Co. Ltd. (Private Equity) Investment ManagersFinance JAFCO Group Co. Ltd. (JAFCO Group) is the private equity arm of the parent firm, JAFCO (TSE: 8595), founded in 1973. The firm is headquartered in Tokyo, Japan. | Private Equity Investor | 01/11/2019 | - |
| Corporate Officer/Principal | 01/11/2019 | - | |
Rege Nephro Co. Ltd.
 Rege Nephro Co. Ltd. Miscellaneous Commercial ServicesCommercial Services Rege Nephro Co. Ltd. is a company based in Kyoto, Japan that specializes in the research, development, production, and sales of renal disease treatment drugs. The Japanese company has developed a unique and realistic approach to induce high-efficiency differentiation from stem cells, with the aim of saving patients suffering from renal failure. The company's research and development activities focus on developing various solutions for renal disease and improving the quality of life of patients suffering from renal disease. Rege Nephro Co. was founded in 2019 by Kenji Nagafune. | Director/Board Member | - | - |
Career history of Akifumi Morinaka
Former positions of Akifumi Morinaka
| Companies | Position | Start | End |
|---|---|---|---|
| CHORDIA THERAPEUTICS INC. | Director/Board Member | - | - |
Statistics
International
| Japan | 4 |
Operational
| Director/Board Member | 2 |
| Private Equity Investor | 1 |
| Corporate Officer/Principal | 1 |
Sectoral
| Finance | 2 |
| Commercial Services | 2 |
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| CHORDIA THERAPEUTICS INC. | Health Technology |
| Private companies | 2 |
|---|---|
JAFCO Group Co. Ltd. (Private Equity)
JAFCO Group Co. Ltd. (Private Equity) Investment ManagersFinance JAFCO Group Co. Ltd. (JAFCO Group) is the private equity arm of the parent firm, JAFCO (TSE: 8595), founded in 1973. The firm is headquartered in Tokyo, Japan. | Finance |
Rege Nephro Co. Ltd.
Rege Nephro Co. Ltd. Miscellaneous Commercial ServicesCommercial Services Rege Nephro Co. Ltd. is a company based in Kyoto, Japan that specializes in the research, development, production, and sales of renal disease treatment drugs. The Japanese company has developed a unique and realistic approach to induce high-efficiency differentiation from stem cells, with the aim of saving patients suffering from renal failure. The company's research and development activities focus on developing various solutions for renal disease and improving the quality of life of patients suffering from renal disease. Rege Nephro Co. was founded in 2019 by Kenji Nagafune. | Commercial Services |
- Stock Market
- Insiders
- Akifumi Morinaka
- Experience
